Lipid carrier systems for targeted drug and gene delivery

被引:81
作者
Hashida, M [1 ]
Kawakami, S [1 ]
Yamashita, F [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
drug delivery system; liposomes; lipid emulsion; gene delivery; targeting;
D O I
10.1248/cpb.53.871
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For effective chemotherapy, it is necessary to deliver therapeutic agents selectively to their target sites, since most drugs are associated with both beneficial effects and side effects. The use of lipid dispersion carrier systems, such as lipid emulsions and liposomes, as carriers of lipophilic drugs has attracted particular interest. A drug delivery system can be defined as a methodology for manipulating drug distribution in the body. Since drug distribution depends on the carrier, administration route, particle size of the carrier, lipid composition of the carrier, electric charge of the carrier and ligand density of the targeting carrier, these factors must be optimized. Recently, the lipid carrier system has also been applied to gene delivery systems for gene therapy. However, in both drug and gene medicine cases, a lack of cell-selectivity limits the wide application of this kind of drug and/or gene therapy. Therefore, lipid carrier systems for targeted drug and gene delivery must be developed for the rational therapy. In this review, we shall focus on the progress of research into lipid carrier systems for drug and gene delivery following systemic or local injection.
引用
收藏
页码:871 / 880
页数:10
相关论文
共 119 条
[2]   Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration [J].
Barron, LG ;
Gagné, L ;
Szoka, FC .
HUMAN GENE THERAPY, 1999, 10 (10) :1683-1694
[3]   LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS [J].
CONSTANTINIDES, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1561-1572
[4]   Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8(+) T cell-, interferon gamma-, and nitric oxide-dependent immunity [J].
Doolan, DL ;
Sedegah, M ;
Hedstrom, RC ;
Hobart, P ;
Charoenvit, Y ;
Hoffman, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1739-1746
[5]   Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages [J].
Erbacher, P ;
Bousser, MT ;
Raimond, J ;
Monsigny, M ;
Midoux, P ;
Roche, AC .
HUMAN GENE THERAPY, 1996, 7 (06) :721-729
[6]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[7]   ENZYME REPLACEMENT VIA LIPOSOMES - VARIATIONS IN LIPID-COMPOSITION DETERMINE LIPOSOMAL INTEGRITY IN BIOLOGICAL-FLUIDS [J].
FINKELSTEIN, MC ;
WEISSMANN, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 587 (02) :202-216
[8]   Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation [J].
Fumoto, S ;
Kawakami, S ;
Ito, Y ;
Shigeta, K ;
Yamashita, F ;
Hashida, M .
MOLECULAR THERAPY, 2004, 10 (04) :719-729
[9]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[10]  
Hara T, 1995, GENE THER, V2, P784